Skip to main content

Animations

MJFF Publications

2821 - 2830 of 8825 Results
Title
Year
  • Year
  • 2017
  • 2016
  • 2015
  • 2018
  • 2008
  • 2010
  • 2014
  • 2015
  • 2017
  • 2018
  • Summary Details
    RESTRICTED
    Title: Validation of Electrochemiluminescence Assays for Highly Sensitive and Reproducible Quantification of α-Synuclein in Cerebrospinal Fluid
    Journal Name: Bioanalysis
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.4155/bio-2017-0005
    Citation Count: 12
  • Summary Details
    RESTRICTED
    Title: Detection of Proteolytic Signatures for Parkinson's Disease
    Journal Name: Future Neurology
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.2217/fnl.16.3
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Bilateral globus pallidus stimulation for severe Tourette's syndrome: a double-blind, randomised crossover trial
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(15)00008-3
    Citation Count: 169
  • Summary Details
    RESTRICTED
    Title: Animal exposure over the life-course and risk of multiple sclerosis: A case-control study within two cohorts of US women
    Journal Name: Multiple Sclerosis and Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.msard.2018.11.015
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Hsp104 antagonizes α-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease
    Journal Name: Journal of Clinical Investigation
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1172/jci35781
    Citation Count: 195
  • Summary Details
    OPEN
    Title: Bioactivity of AAV2‐neurturin gene therapy (CERE‐120): Differences between Parkinson's disease and nonhuman primate brains
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.23442
    Citation Count: 167
  • Summary Details
    RESTRICTED
    Title: Enteric GFAP expression and phosphorylation in Parkinson's disease
    Journal Name: Journal of Neurochemistry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/jnc.12742
    Citation Count: 172
  • Summary Details
    OPEN
    Title: Feasibility of Virtual Research Visits in Fox Trial Finder
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: unspecified-oa
    DOI - Digital Object Identifier: 10.3233/jpd-150549
    Citation Count: 64
  • Summary Details
    OPEN
    Title: Cystinosin, the small GTPase Rab11, and the Rab7 effector RILP regulate intracellular trafficking of the chaperone-mediated autophagy receptor LAMP2A
    Journal Name: Journal of Biological Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1074/jbc.m116.764076
    Citation Count: 81
  • Summary Details
    OPEN
    Title: The Parkinson's disease gene product DJ-1 modulates miR-221 to promote neuronal survival against oxidative stress
    Journal Name: Redox Biology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.redox.2018.07.021
    Citation Count: 81
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.